Opus Genetics, Inc. Comprehensive Income
Opus Genetics, Inc. (IRD) reported Comprehensive Income of -$8.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$8.10M.
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$65.53M.
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$16.52M.
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$17.45M.
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$49.59M.
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$57.53M.
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$9.99M, a 155.83% decline from fiscal 2022.
- Opus Genetics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $17.89M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.10M 10-Q · filed 2026-08-06 | -$73.63M 10-Q · filed 2026-08-06 | -$90.16M derived: sum of 3 quarters · filed 2026-08-06 | -$107.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$65.53M 10-Q · filed 2026-05-12 | -$82.06M derived: sum of 2 quarters · filed 2026-05-12 | -$99.51M derived: sum of 3 quarters · filed 2026-05-12 | -$106.93M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$16.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$33.98M derived: sum of 2 quarters · filed 2026-03-12 | -$41.40M derived: sum of 3 quarters · filed 2026-08-06 | -$49.59M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$17.45M 10-Q · filed 2025-11-12 | -$24.87M derived: sum of 2 quarters · filed 2026-08-06 | -$33.07M 10-Q · filed 2025-11-12 | -$68.20M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$7.42M 10-Q · filed 2026-08-06 | -$15.61M 10-Q · filed 2026-08-06 | -$50.75M derived: sum of 3 quarters · filed 2026-08-06 | -$58.27M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$8.19M 10-Q · filed 2026-05-12 | -$43.33M derived: sum of 2 quarters · filed 2026-05-12 | -$50.85M derived: sum of 3 quarters · filed 2026-05-12 | -$58.62M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | -$35.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | -$42.66M derived: sum of 2 quarters · filed 2026-03-12 | -$50.43M derived: sum of 3 quarters · filed 2026-03-12 | -$57.53M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$7.53M 10-Q · filed 2025-11-12 | -$15.29M derived: sum of 2 quarters · filed 2025-11-12 | -$22.40M 10-Q · filed 2025-11-12 | -$27.19M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$7.76M 10-Q · filed 2025-08-13 | -$14.87M 10-Q · filed 2025-08-13 | -$19.67M derived: sum of 3 quarters · filed 2025-08-13 | -$14.11M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | -$7.11M 10-Q · filed 2025-05-15 | -$11.90M derived: sum of 2 quarters · filed 2025-05-15 | -$6.34M derived: sum of 3 quarters · filed 2025-05-15 | -$11.30M derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$4.79M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $766.00K derived: sum of 2 quarters · filed 2025-03-31 | -$4.20M derived: sum of 3 quarters · filed 2025-03-31 | -$9.99M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $5.56M 10-Q · filed 2024-11-12 | $600.00K derived: sum of 2 quarters · filed 2024-11-12 | -$5.19M 10-Q · filed 2024-11-12 | $28.75M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | -$4.96M 10-Q · filed 2024-08-13 | -$10.75M 10-Q · filed 2024-08-13 | $23.19M derived: sum of 3 quarters · filed 2024-08-13 | $18.66M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | -$5.79M 10-Q · filed 2024-05-10 | $28.15M derived: sum of 2 quarters · filed 2024-05-10 | $23.62M derived: sum of 3 quarters · filed 2024-05-10 | $18.69M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $33.94M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $29.41M derived: sum of 2 quarters · filed 2024-03-08 | $24.48M derived: sum of 3 quarters · filed 2024-03-08 | $17.89M 10-K · filed 2024-03-08 | ||||
| 2022-09-30 | -$4.53M 10-Q · filed 2023-11-13 | -$9.46M derived: sum of 2 quarters · filed 2023-11-13 | -$16.05M 10-Q · filed 2023-11-13 | -$22.37M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | -$4.93M 10-Q · filed 2023-08-11 | -$11.52M 10-Q · filed 2023-08-11 | -$17.84M derived: sum of 3 quarters · filed 2023-08-11 | -$22.07M derived: sum of 4 quarters · filed 2023-08-11 | ||||
| 2022-03-31 | -$6.59M 10-Q · filed 2023-05-15 | -$12.91M derived: sum of 2 quarters · filed 2023-05-15 | -$17.14M derived: sum of 3 quarters · filed 2023-05-15 | -$24.27M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$6.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$10.54M derived: sum of 2 quarters · filed 2023-03-30 | -$17.68M derived: sum of 3 quarters · filed 2023-03-30 | -$56.69M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$4.23M 10-Q · filed 2022-11-04 | -$11.37M derived: sum of 2 quarters · filed 2022-11-04 | -$50.38M 10-Q · filed 2022-11-04 | -$69.06M derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2021-06-30 | -$7.14M 10-Q · filed 2022-08-12 | -$46.15M 10-Q · filed 2022-08-12 | -$64.83M derived: sum of 3 quarters · filed 2022-08-12 | -$66.08M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | -$39.01M 10-Q · filed 2022-05-13 | -$57.69M derived: sum of 2 quarters · filed 2022-05-13 | -$58.94M derived: sum of 3 quarters · filed 2022-05-13 | -$60.55M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$18.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$19.93M derived: sum of 2 quarters · filed 2022-03-24 | -$21.53M derived: sum of 3 quarters · filed 2022-03-24 | -$24.62M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | -$1.25M 10-Q · filed 2021-11-12 | -$1.40M 10-Q · filed 2020-10-29 | -$2.85M derived: sum of 2 quarters · filed 2021-11-12 | -$5.94M 10-Q · filed 2021-11-12 | -$4.50M 10-Q · filed 2020-10-29 | -$5.37M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$1.60M 10-Q · filed 2021-08-12 | -$2.51M 10-Q · filed 2020-08-14 | -$4.69M 10-Q · filed 2021-08-12 | -$3.10M 10-Q · filed 2020-08-14 | -$4.12M derived: sum of 3 quarters · filed 2021-08-12 | -$6.08M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$3.09M 10-Q · filed 2021-05-07 | -$588.85K 10-Q · filed 2020-05-07 | -$2.52M derived: sum of 2 quarters · filed 2021-05-07 | -$4.47M derived: sum of 3 quarters · filed 2021-05-07 | -$6.92M derived: sum of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | $571.83K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$1.39M derived: sum of 2 quarters · filed 2021-03-11 | -$3.83M derived: sum of 3 quarters · filed 2021-03-11 | -$6.17M 10-K · filed 2021-03-11 | -$8.62M 10-K · filed 2020-02-21 | |||
| 2019-09-30 | -$1.96M 10-Q · filed 2020-10-29 | -$4.40M derived: sum of 2 quarters · filed 2020-10-29 | -$6.74M 10-Q · filed 2020-10-29 | -$9.85M derived: sum of 4 quarters · filed 2020-10-29 | ||||
| 2019-06-30 | -$2.44M 10-Q · filed 2020-08-14 | -$4.78M 10-Q · filed 2020-08-14 | -$7.89M derived: sum of 3 quarters · filed 2020-08-14 | -$13.19M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$2.34M 10-Q · filed 2020-05-07 | -$5.44M derived: sum of 2 quarters · filed 2020-05-07 | -$10.75M derived: sum of 3 quarters · filed 2020-05-07 | -$14.56M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$8.41M derived: sum of 2 quarters · filed 2020-02-21 | -$12.22M derived: sum of 3 quarters · filed 2020-02-21 | -$14.33M 10-K · filed 2020-02-21 | ||||
| 2018-09-30 | -$5.30M 10-Q · filed 2019-11-06 | -$9.12M derived: sum of 2 quarters · filed 2019-11-06 | -$11.22M 10-Q · filed 2019-11-06 | -$14.86M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | -$3.81M 10-Q · filed 2019-08-07 | -$5.92M 10-Q · filed 2019-08-07 | -$9.56M derived: sum of 3 quarters · filed 2019-08-07 | -$10.58M derived: sum of 4 quarters · filed 2019-08-07 | ||||
| 2018-03-31 | -$2.11M 10-Q · filed 2019-05-10 | -$5.74M derived: sum of 2 quarters · filed 2019-05-10 | -$6.77M derived: sum of 3 quarters · filed 2019-05-10 | -$5.84M derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | -$3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$4.66M derived: sum of 2 quarters · filed 2019-03-07 | -$3.73M derived: sum of 3 quarters · filed 2019-03-07 | -$25.35M 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | -$1.03M 10-Q · filed 2018-11-02 | -$98.66K derived: sum of 2 quarters · filed 2018-11-02 | -$21.71M 10-Q · filed 2018-11-02 | -$22.24M derived: sum of 4 quarters · filed 2018-11-02 | ||||
| 2017-06-30 | $927.68K 10-Q · filed 2018-08-03 | -$20.68M 10-Q · filed 2018-08-03 | -$21.21M derived: sum of 3 quarters · filed 2018-08-03 | -$24.08M derived: sum of 4 quarters · filed 2018-08-03 | ||||
| 2017-03-31 | -$21.61M 10-Q · filed 2018-05-04 | -$22.14M derived: sum of 2 quarters · filed 2018-05-04 | -$25.01M derived: sum of 3 quarters · filed 2018-05-04 | -$26.77M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2016-12-31 | -$526.95K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$3.40M derived: sum of 2 quarters · filed 2018-03-09 | -$5.16M derived: sum of 3 quarters · filed 2018-03-09 | -$9.30M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | -$2.87M 10-Q · filed 2017-11-03 | -$4.64M derived: sum of 2 quarters · filed 2017-11-03 | -$8.77M 10-Q · filed 2017-11-03 | -$11.65M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-06-30 | -$1.76M 10-Q · filed 2017-08-04 | -$5.89M 10-Q · filed 2017-08-04 | -$8.77M derived: sum of 3 quarters · filed 2018-03-09 | -$12.80M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2016-03-31 | -$4.13M 10-Q · filed 2017-05-03 | -$7.01M derived: sum of 2 quarters · filed 2018-03-09 | -$11.03M derived: sum of 3 quarters · filed 2018-03-09 | -$14.26M derived: sum of 4 quarters · filed 2018-03-09 | ||||
| 2015-12-31 | -$2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$6.90M derived: sum of 2 quarters · filed 2018-03-09 | -$10.13M derived: sum of 3 quarters · filed 2018-03-09 | -$14.37M 10-K · filed 2018-03-09 | ||||
| 2015-09-30 | -$4.03M 10-Q · filed 2016-11-04 | -$7.25M derived: sum of 2 quarters · filed 2016-11-04 | -$11.49M 10-Q · filed 2016-11-04 | -$13.69M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-06-30 | -$3.23M 10-Q · filed 2016-08-05 | -$7.47M 10-Q · filed 2016-08-05 | -$9.67M derived: sum of 3 quarters · filed 2017-02-24 | -$11.62M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2015-03-31 | -$4.24M 10-Q · filed 2016-05-06 | -$6.44M derived: sum of 2 quarters · filed 2017-02-24 | -$8.39M derived: sum of 3 quarters · filed 2017-02-24 | -$8.19M derived: sum of 4 quarters · filed 2017-02-24 | ||||
| 2014-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | -$4.15M derived: sum of 2 quarters · filed 2017-02-24 | -$3.95M derived: sum of 3 quarters · filed 2017-02-24 | -$18.56M 10-K · filed 2017-02-24 | ||||
| 2014-09-30 | -$1.95M 10-Q · filed 2015-11-02 | -$1.75M derived: sum of 2 quarters · filed 2015-11-02 | -$16.35M 10-Q · filed 2015-11-02 | -$19.07M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-06-30 | $194.46K 10-Q · filed 2015-08-07 | -$14.41M 10-Q · filed 2015-08-07 | -$17.13M derived: sum of 3 quarters · filed 2016-03-14 | -$19.27M derived: sum of 4 quarters · filed 2016-03-14 | ||||
| 2014-03-31 | -$14.60M 10-Q · filed 2015-05-08 | -$17.32M derived: sum of 2 quarters · filed 2016-03-14 | -$19.46M derived: sum of 3 quarters · filed 2016-03-14 | |||||
| 2013-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | -$4.86M derived: sum of 2 quarters · filed 2016-03-14 | -$9.50M 10-K · filed 2016-03-14 | |||||
| 2013-09-30 | -$2.14M 10-Q · filed 2014-11-12 | -$6.78M 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |